These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 77579)

  • 1. The diagnostic value of serum copper levels and other hematochemical parameters in malignancies.
    Pizzolo G; Savarin T; Molino AM; Ambrosetti A; Todeschini G; Vettore L
    Tumori; 1978 Feb; 64(1):55-61. PubMed ID: 77579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
    Oertel J; Gerhartz H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHANGES IN SERUM ALPHA-2 GLOBULINS IN RETICULOSES.
    MALPAS JS; FAIRLEY GH
    J Clin Pathol; 1964 Nov; 17(6):651-4. PubMed ID: 14227435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin in hematologic malignancies.
    Matzner Y; Konijn AM; Hershko C
    Am J Hematol; 1980; 9(1):13-22. PubMed ID: 7001894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 10. [HL-A antigens and malignant hematological diseases].
    Jeannet M; Alberto P; Wyss M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1798-800. PubMed ID: 5291103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-2-microglobulin review: its relevance in clinical oncology.
    Cooper EH; Plesner T
    Med Pediatr Oncol; 1980; 8(4):323-34. PubMed ID: 6161299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic abnormalities in chronic lymphocytic leukemia and cancer sera.
    Werthamer S; Amaral L
    Am J Clin Pathol; 1976 Jan; 65(1):40-8. PubMed ID: 55071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement in hematological neoplasias.
    Batlle Fonrodona FJ; López Fernández MF; Vicente García V; Corral Alonso M; López Borrasca A
    Allergol Immunopathol (Madr); 1979; 7(1):39-46. PubMed ID: 474324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iron, copper and iron/copper index in the serum during remission of acute leukemia in children].
    Legutko L
    Acta Haematol Pol; 1978; 9(3):179-85. PubMed ID: 281085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
    Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
    Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
    Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vitamin B 12 and vitamin B 12 binding capacity in chronic myelogenous leukemia and other disorders.
    Rosner F; Schreiber ZA
    Am J Med Sci; 1972 Jun; 263(6):473-80. PubMed ID: 4505888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.